受业绩前景低迷影响，丹麦制药巨头诺和诺德股价大跌。受2026年业绩展望大幅低于市场预期影响，当地时间周三（2月4日），丹麦制药巨头诺和诺德欧股开盘后股价大幅下跌，一度跌超20%。此前一天，诺和诺德在纽交所上市的存托凭证已经下跌14%，今日美股盘前，该股一度跌超5%，目前跌幅小幅收窄。去年7月，诺和诺德也以美国市场形势严峻为由，下调了2025年的业绩指引，导致公司股价在当日暴跌23%。业绩指引不及...
Source Link受业绩前景低迷影响，丹麦制药巨头诺和诺德股价大跌。受2026年业绩展望大幅低于市场预期影响，当地时间周三（2月4日），丹麦制药巨头诺和诺德欧股开盘后股价大幅下跌，一度跌超20%。此前一天，诺和诺德在纽交所上市的存托凭证已经下跌14%，今日美股盘前，该股一度跌超5%，目前跌幅小幅收窄。去年7月，诺和诺德也以美国市场形势严峻为由，下调了2025年的业绩指引，导致公司股价在当日暴跌23%。业绩指引不及...
Source LinkDisclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.